Tower Research Capital (TRC)’s Orgenesis Inc. Common Stock ORGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,471
| Closed | -$6.56K | – | 6165 |
|
|
2024
Q3 | $6.56K | Buy |
1,471
+1,408
| +2,235% | +$9.39K | ﹤0.01% | 4133 |
|
|
2024
Q2 | $379 | Buy |
+63
| New | +$331 | ﹤0.01% | 5342 |
|
|
2023
Q3 | – | Sell |
-216
| Closed | -$3K | – | 6330 |
|
|
2023
Q2 | $3K | Sell |
216
-1,059
| -83% | -$12.6K | ﹤0.01% | 5128 |
|
|
2023
Q1 | $15K | Buy |
1,275
+96
| +8% | +$1.8K | ﹤0.01% | 3839 |
|
|
2022
Q4 | $23K | Buy |
1,179
+210
| +22% | +$3.58K | ﹤0.01% | 3019 |
|
|
2022
Q3 | $14K | Buy |
969
+948
| +4,514% | +$17.8K | ﹤0.01% | 4234 |
|
|
2022
Q2 | $1K | Buy |
21
+14
| +200% | +$390 | ﹤0.01% | 5891 |
|
|
2022
Q1 | $0 | Sell |
7
-160
| -96% | -$4.86K | ﹤0.01% | 6679 |
|
|
2021
Q4 | $5K | Buy |
167
+118
| +241% | +$4.62K | ﹤0.01% | 5209 |
|
|
2021
Q3 | $2K | Sell |
49
-276
| -85% | -$13.9K | ﹤0.01% | 5319 |
|
|
2021
Q2 | $16K | Sell |
325
-300
| -48% | -$15.1K | ﹤0.01% | 4095 |
|
|
2021
Q1 | $36K | Sell |
625
-261
| -29% | -$17K | ﹤0.01% | 3408 |
|
|
2020
Q4 | $40K | Sell |
886
-822
| -48% | -$39.6K | ﹤0.01% | 3332 |
|
|
2020
Q3 | $86K | Buy |
1,708
+1,618
| +1,798% | +$87.7K | ﹤0.01% | 3261 |
|
|
2020
Q2 | $5K | Buy |
+90
| New | +$5.45K | ﹤0.01% | 4305 |
|
|
2019
Q4 | – | Sell |
-10
| Closed | – | – | 4534 |
|
|
2019
Q3 | $0 | Buy |
+10
| New | +$446 | ﹤0.01% | 4602 |
|
|
2019
Q2 | – | Sell |
-75
| Closed | -$4K | – | 4432 |
|
|
2019
Q1 | $4K | Buy |
+75
| New | +$3.74K | ﹤0.01% | 3214 |
|
|
2018
Q4 | – | Sell |
-53
| Closed | -$3K | – | 4479 |
|
|
2018
Q3 | $3K | Buy |
+53
| New | +$3.59K | ﹤0.01% | 3352 |
|
Tower Research Capital (TRC)'s ORGS Position: Q4 2024 in Review
Tower Research Capital (TRC) sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2024, closing a stake of 1,471 shares — an estimated $6.56K sold.
Tower Research Capital (TRC) first reported a position in ORGS in Q3 2018 and held it in 18 quarters. The position peaked at $86K in Q3 2020. 0 funds tracked by Wall St. Rank hold ORGS as of Q4 2024.
- Tower Research Capital (TRC) reported no remaining Orgenesis Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,471 Orgenesis Inc. Common Stock shares in Q4 2024, an estimated $6.56K.
- Tower Research Capital (TRC) first reported a position in Orgenesis Inc. Common Stock in Q3 2018 and held it in 18 quarters.
- Tower Research Capital (TRC)'s Orgenesis Inc. Common Stock position peaked at $86K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.